Evidence map›Paper›PMID 41686257›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Comorbidity, treatment toxicity and satisfaction with cancer care: an international cross-sectional study based on the EORTC PATSAT-C33 and OUT-PATSAT7.

Anne Brédart, Jean-Luc Kop, Omar Shamieh, Louis Fox, Waleed Alrjowb, Thierry Conroy, Nazim Serdar Turhal, Ignacio Juan Arraras, Renée Bultijnck, Amélie Harle and 15 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05989191 (An International Field Study for the Reliability and Validity of the EORTC PATSAT-C33 and the EORTC OUT-PATSAT7 Questionnaires), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05989191 active not recruitingnot on this map

An International Field Study for the Reliability and Validity of the EORTC PATSAT-C33 and the EORTC OUT-PATSAT7 Questionnaires

TypeobservationalSponsorInstitut CurieRan2019 to 2025Enrolled690ConditionsCancer
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Anne BrédartPsycho-Oncology Unit, SHARE Team, Institut Curie, PSL, Paris, & Health Process & Psychopathology Laboratory, LPPS EA 4057, University Paris Cité, Boulogne Billancourt, France. anne.bredart@curie.fr.ORCID http://orcid.org/0000-0002-1864-5371
Jean-Luc KopUniversité de Lorraine, 2LPN, Nancy, France.ORCID http://orcid.org/0000-0002-6963-8411
Omar ShamiehDepartment of Palliative Medicine, King Hussein Cancer Center; Centre for palliative and Cancer Care in Conflict (CPCCC), Faculty of Medicine, University of Jordan, Amman, Jordan.ORCID http://orcid.org/0000-0002-3635-8624
Louis FoxTransforming cancer OUtcomes through Research (TOUR), King's College London, London, England.ORCID http://orcid.org/0000-0002-8280-1797
Waleed AlrjowbKing Hussein Cancer Center, Amman, Jordan.ORCID http://orcid.org/0000-0001-6098-9891
Thierry ConroyUniversité de Lorraine, Inserm INSPIIRE, Institut de Cancérologie de Lorraine, Nancy, France.ORCID http://orcid.org/0000-0001-7548-284X
Nazim Serdar TurhalAnadolu Medical Centre, Çayırova, Turkey.ORCID http://orcid.org/0000-0002-1013-5676
Ignacio Juan ArrarasDepartment of Oncology, Hospital of Navarre, Pamplona, Spain.ORCID http://orcid.org/0000-0002-4415-2570
Renée BultijnckDepartment of Human Structure and Repair, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0003-4122-2323
Amélie HarleUniversity Hospitals Dorset, Poole and Bournemouth, Bournemouth, England.ORCID http://orcid.org/0000-0001-7743-9626
Mieke Van HemelrijckTransforming cancer OUtcomes through Research (TOUR), King's College London, London, England.ORCID http://orcid.org/0000-0002-7317-0858
Eleonora PintoHospital Psychology Unit, Veneto Institute of Oncology IOV IRCCS, Padova, Italy.ORCID http://orcid.org/0000-0001-5404-5958
Eric RothDepartment of Psychology, Universidad Católica Boliviana "San Pablo", Obrajes, La Paz, Bolivia.ORCID http://orcid.org/0000-0003-1909-2462
Georgios IoannidisOncology Department, Nicosia General Hospital, State Health Services Organization, Nicosia, Cyprus.ORCID http://orcid.org/0000-0003-2535-7279
Anna CostantiniPsycho-Oncology Unit, Sant'Andrea Universitary Hospital, Rome, Italy.ORCID http://orcid.org/0000-0002-5955-5209
Tara ChalkMount Vernon Cancer Centre, East & North Hertfordshire Teaching NHS Trust, London, UK.ORCID http://orcid.org/0000-0003-2964-1891
Teresa YoungMount Vernon Cancer Centre, East & North Hertfordshire Teaching NHS Trust, London, UK.ORCID http://orcid.org/0000-0003-0367-2980
Gudrun RohdeDepartment of Health and Nursing, University of Agder, Kristiansand, Norway.ORCID http://orcid.org/0000-0002-8538-7237
Hiroto IshikiDepartment of Palliative Medicine, National Cancer Centre Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0002-0800-2161
Yuichiro KikawaKansai Medical University Hospital, Hirataka, Osaka, Japan.ORCID http://orcid.org/0000-0002-3852-5991
Heike SchmidtUniversity Clinic and Outpatient Clinic for Radiotherapy and Institute for Health and Nursing Science, Medical Faculty, Martin Luther University Halle Wittenberg, Halle, Germany.ORCID http://orcid.org/0000-0002-0922-4022
Vassilios VassiliouBank of Cyprus Oncology Centre, Nicosia, Cyprus.
Stephanie ShaylerUniversity Hospitals Birmingham NHS Foundation Trust, Birmingham, England.
Frédéric MarchalDépartement de chirurgie, Université de Lorraine, CNRS, CRAN, UMR 7039, Institut de Cancérologie de Lorraine, Nancy, France.ORCID http://orcid.org/0000-0002-7685-6070
Jens LehmannUniversity Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-4670-7517

Funding

European Organisation for Research and Treatment of Cancer 007/2018
6 · The paper itself

Abstract

purposeThis multi-national cross-sectional study assessed socio-demographic and clinical determinants of satisfaction with cancer care in patients enrolled from hospital inpatient and outpatient settings.

methodsSix hundred ninety consecutive patients with any cancer type or stage including 558 outpatients were approached between October 2019 and October 2023 in 12 countries (20 cancer centres) from Asia, Europe, the Middle East and South America. Among them, 675 (98%) and 521 (93%) completed the EORTC PATSAT-C33 and the OUT-PATSAT7, respectively. Multi-level analyses were performed accounting for institutional differences in satisfaction with care.

resultsSelf-reported quality of life was positively related to all thirteen PATSAT-C33 and OUT-PATSAT7 satisfaction with care domains. Treatment toxicities and the absence of comorbidity predicted lower satisfaction with nine and ten care domains, respectively. Patients in day hospitals were significantly less satisfied with nurses' availability, care coordination and health professionals' information. Tumour site predicted satisfaction with care transition hospital-home. Not being married/with a partner and shorter travels to the hospital predicted less satisfaction with five and two care domains, respectively.

conclusionThis study illustrates the value of collecting patients' feedback on their cancer care experience. It informs health policy, pointing out targets for improving satisfaction with cancer care across several institutions and cultures worldwide.

trial registrationClinicalTrials.gov under ID: NCT05989191, August 2, 2023.

Indexed as

NeoplasmsPatient SatisfactionQuality of LifeAdultAgedAged, 80 and overComorbidityCross-Sectional StudiesEuropeFemaleHumansMaleMiddle AgedCancer careComorbidityPatient satisfactionSelf-reported quality of lifeToxicity

Identifiers

PMID41686257
PMCPMC12904965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.